Revenue, last quarter
$0
−100% vs same quarter last year
Net income
−$25.2M
−150.6% vs same quarter last year
EPS, diluted
−$0.14
+0% vs same quarter last year
Operating cash flow
−$17.5M
−95.7% vs same quarter last year
Source: SEC XBRL filings · latest filing
- Revenue
- Net income
Show the numbers
| Year | Revenue | Net income |
|---|---|---|
| FY25 | $1M | −$48.8M |
| FY24 | $5.7M | −$75.4M |
| FY23 | $1.7M | −$87.3M |
| FY22 | $652K | −$101.9M |
| FY21 | $30M | −$45M |
| FY20 | $9.9M | −$36.6M |
| FY19 | $9.9M | −$24M |
| FY18 | - | - |
- Operating margin
- Net margin
Show the numbers
| Year | Operating margin | Net margin |
|---|---|---|
| FY25 | −5150.8% | −4880.9% |
| FY24 | −1408.3% | −1318.1% |
| FY23 | −5549.6% | −5268.4% |
| FY22 | −15848% | −15635.7% |
| FY21 | −150.8% | −149.8% |
| FY20 | −371.8% | −368.5% |
| FY19 | −253.5% | −242.6% |
| FY18 | - | - |
Show the numbers
| Year | Free cash flow |
|---|---|
| FY25 | −$40M |
| FY24 | −$60.6M |
| FY23 | −$81.6M |
| FY22 | −$106.1M |
| FY21 | −$65M |
| FY20 | −$34.4M |
| FY19 | −$21.4M |
| FY18 | - |
- Shattuck Labs
- Healthcare median
Show the numbers
| Year | Shattuck Labs | Healthcare median |
|---|---|---|
| FY25 | −4880.9% | −30.6% |
| FY24 | −1318.1% | −47% |
| FY23 | −5268.4% | −58% |
| FY22 | −15635.7% | −80.4% |
| FY21 | −149.8% | −71.8% |
| FY20 | −368.5% | −62.2% |
| FY19 | −242.6% | −46.2% |
| FY18 | - | −49.6% |